undefined
EUTM file information

017912873

Theramex

June 4, 2018

Trademark Summary

The trademark application Theramex was filed by Theramex HQ UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on July 5, 2018, and it was registered by office on October 12, 2018 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and address of the trademark registration was recorded on July 31, 2018. Change of name and professional address of the trademark registration was recorded on October 1, 2018. Change of name and professional address of the trademark registration was recorded on May 16, 2019. Appointment and Replacement of representative of the trademark registration was recorded on November 11, 2019. Change of name and address of the trademark registration was recorded on August 15, 2023.

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Anti-fungal pharmaceutical preparations
    2. Contraceptive preparations
    3. Contraceptive sponges
    4. Chemical contraceptives
    5. Oral contraceptives
    6. Dermatological preparations
    7. Diagnostic preparations
    8. Pharmaceutical preparations and substances for use in relation to women's health
    9. Pharmaceutical preparations and substances containing steroids
    10. Pharmaceutical preparations and substances containing hormones
    11. Pharmaceutical preparations and substances in the nature of hormone replacement therapy [HRT]
    12. Pharmaceutical preparations and substances for use in relation to reproductive health
    13. Pharmaceutical preparations and substances for use in relation to contraception
    14. Pharmaceutical preparations and substances for use in relation to conception
    15. Pharmaceutical preparations and substances for use in relation to fertility
    16. Fertility enhancement preparations
    17. Pharmaceutical preparations and substances for use in relation to the treatment of infertility
    18. Pharmaceutical preparations and substances for use in endocrinology
    19. Pharmaceutical preparations and substances for use in gynaecology
    20. Pharmaceutical preparations and substances for use in rheumatology
    21. Pharmaceutical preparations and substances for use in dermatology
    22. Pharmaceutical preparations for the treatment of menopause
    23. Pharmaceutical preparations and substances for the alleviation of menopause-related symptoms
    24. Pharmaceutical preparations and substances for the treatment of osteoperosis
    25. Pharmaceutical preparations and substances for the alleviation of osteoperosis-related symptoms
    26. Pharmaceutical preparations and substances for the treatment of cartilage disorders
    27. Pharmaceutical preparations and substances for the treatment of bone disorders
    28. Pharmaceutical preparations and substances for the treatment of bone loss
    29. Pharmaceutical preparations and substances for the treatment of arthritis
    30. Pharmaceutical preparations and substances for the treatment of calcium deficiency
    31. Pharmaceutical preparations and substances being calcium regulators
    32. Pharmaceutical preparations and substances for the treatment of Paget's disease
    33. Phosphates for pharmaceutical purposes
    34. Vitamin supplements
    35. Mineral supplements
    36. Calcium supplements
    37. All the above being for human use and none being for dental use or for use in relation to oral hygiene.
  • The mark was filed in class 10 with following description of goods:
    1. Medical apparatus and instruments
    2. Gynaecological apparatus
    3. Gynaecological instruments
    4. Medical diagnostic instruments
    5. Diagnostic apparatus for medical purposes
    6. Contraceptive appliances
    7. Contraceptive devices
    8. Contraceptive apparatus
    9. Medical apparatus and instruments in relation to reproductive health
    10. Medical devices in relation to reproductive health
    11. Self-injectors for subcutaneous administration of pharmaceutical preparations for the treatment of infertility
    12. All the above being for human use and none being for dental use or for use in relation to oral hygiene.